Santhera Pharmaceuticals (Schweiz)
Latest round
- Series C
Last raised
- Oct 2006
Total raised
- $48M
Investors
- 15
About Santhera Pharmaceuticals (Schweiz)
Santhera Pharmaceuticals specializes in creating treatments for rare neuromuscular diseases. Founded in 2004 in Liestal, Switzerland, the company has successfully completed 19 deals to date.20 million.Santhera Pharmaceuticals specializes in the development and commercialization of innovative medicines aimed at addressing the needs of patients suffering from rare neuromuscular diseases. The company’s core products include AGAMREE® (vamorolone), which targets Duchenne muscular dystrophy (DMD), a condition that severely impacts the mobility and quality of life of affected individuals. Santhera’s products are designed to provide treatment options where none previously existed, thereby improving health outcomes for patients. The company primarily serves healthcare professionals, patients, and caregivers across various geographical markets, including Europe and North America.90. The company operates on a business-to-business (B2B) model, partnering with wholesalers and healthcare institutions to distribute its medications, particularly AGAMREE® (vamorolone).Santhera Pharmaceuticals plans to expand its product portfolio with new medications targeting rare neuromuscular diseases, with potential launches expected within the next few years. The company is also looking to enter new markets in Europe and North America by the end of 2024.
Who invested in Santhera Pharmaceuticals (Schweiz)
15 investors across 3 rounds
See all investors in Santhera Pharmaceuticals (Schweiz)
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Santhera Pharmaceuticals (Schweiz)
Who invested in Santhera Pharmaceuticals (Schweiz)?
Santhera Pharmaceuticals (Schweiz) has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Santhera Pharmaceuticals (Schweiz) raised?
Santhera Pharmaceuticals (Schweiz) has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Santhera Pharmaceuticals (Schweiz) last raise money?
Santhera Pharmaceuticals (Schweiz)'s most recent round on record is a Series C, in Oct 2006.
What does Santhera Pharmaceuticals (Schweiz) do?
Santhera Pharmaceuticals specializes in creating treatments for rare neuromuscular diseases.
Where is Santhera Pharmaceuticals (Schweiz) headquartered?
Santhera Pharmaceuticals (Schweiz) is headquartered in Switzerland.
Which VCs invest in companies like Santhera Pharmaceuticals (Schweiz)?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at Santhera Pharmaceuticals (Schweiz)'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Santhera Pharmaceuticals (Schweiz)? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.